• About us
• Contact

Advertisement

Organisation › Details

Biognosys AG

At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that can dramatically improve human health. We enable life science researchers, biomarker and drug hunters to look at the proteome from every angle with our versatile portfolio of proprietary next-generation proteomics services, software, and kits, including the TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms and flagship proteomics software Spectronaut®. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Biognosys’ unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for biomarker and biopharma R&D, development and translational research. *

 

	Start	2008-09-09 splitoff
	Group	Bruker (Group)
	Predecessor	ETH Zürich (ETHZ)
	Industry	proteomics
	Industry 2	multiple reaction monitoring (MRM) technology
	Person	Rinner, Oliver (Biognosys 202109 CEO + Co-Founder)
	Person 2	Novak, Lidia (Biognosys 2019089 CFO)
	Region	Schlieren ZH
	Country	Switzerland
	Street	21 Wagistr.
	City	8952 Schlieren ZH
	Tel	+41-44-738-2040
		Address record changed: 2023-03-27
Basic data	Employees	B: 11 to 50 (2022-01-01)
		* Document for »About Section«: Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne.
		Record changed: 2023-07-10

Advertisement

More documents for Bruker (Group)

• [1] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
• [2] Bruker Corporation. (10/3/23). "Press Release: Bruker Completes Acquisition of PhenomeX". Billerica, MA....
• [3] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
• [4] Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA....
• [5] Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA....
• [6] Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA....
• [7] Berkeley Lights, Inc.. (3/21/23). "Press Release: Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company". Emeryville, CA....
• [8] Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg....
• [9] Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne....
• [10] Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.